Product NDC: | 0029-1526 |
Proprietary Name: | BACTROBAN |
Non Proprietary Name: | mupirocin calcium |
Active Ingredient(s): | 20 mg/g & nbsp; mupirocin calcium |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0029-1526 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050703 |
Marketing Category: | NDA |
Start Marketing Date: | 19960410 |
Package NDC: | 0029-1526-11 |
Package Description: | 10 CARTON in 1 PACKAGE (0029-1526-11) > 1 TUBE in 1 CARTON (0029-1526-03) > 1 g in 1 TUBE |
NDC Code | 0029-1526-11 |
Proprietary Name | BACTROBAN |
Package Description | 10 CARTON in 1 PACKAGE (0029-1526-11) > 1 TUBE in 1 CARTON (0029-1526-03) > 1 g in 1 TUBE |
Product NDC | 0029-1526 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | mupirocin calcium |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 19960410 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | MUPIROCIN CALCIUM |
Strength Number | 20 |
Strength Unit | mg/g |
Pharmaceutical Classes | RNA Synthetase Inhibitor Antibacterial [EPC],RNA Synthetase Inhibitors [MoA] |